Mr Russell L Fry Ii, MD | |
5187 Us Route 60 E, Ste 6, Huntington, WV 25705-2076 | |
(304) 691-8800 | |
(304) 302-0221 |
Full Name | Mr Russell L Fry Ii |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 24 Years |
Location | 5187 Us Route 60 E, Huntington, West Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114981826 | NPI | - | NPPES |
5902537 | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 200501699 (North Carolina) | Secondary |
207W00000X | Ophthalmology | 21418 (West Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Mary's Medical Center | Huntington, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St. Mary's Himg, Llc | 8729406459 | 74 |
News Archive
A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in a clinical trial in Australia for medically refractory epilepsy.
BD Biosciences, a segment of BD, announced today a further expansion of its Research Grant program, adding $100,000 worth of reagents, cell culture tools and labware to support promising stem cell research.
Researchers at Osaka University have developed a computer method that uses magnetic resonance imaging (MRI) and machine learning to rapidly forecast genetic mutations in glioma tumors, which occur in the brain or spine. The work may help glioma patients to receive more suitable treatment faster, giving better outcomes.
Ironwood Pharmaceuticals, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the offering have not yet been determined.
› Verified 4 days ago
Entity Name | St. Mary's Himg, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184233454 PECOS PAC ID: 8729406459 Enrollment ID: O20200914000288 |
News Archive
A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in a clinical trial in Australia for medically refractory epilepsy.
BD Biosciences, a segment of BD, announced today a further expansion of its Research Grant program, adding $100,000 worth of reagents, cell culture tools and labware to support promising stem cell research.
Researchers at Osaka University have developed a computer method that uses magnetic resonance imaging (MRI) and machine learning to rapidly forecast genetic mutations in glioma tumors, which occur in the brain or spine. The work may help glioma patients to receive more suitable treatment faster, giving better outcomes.
Ironwood Pharmaceuticals, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the offering have not yet been determined.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Russell L Fry Ii, MD 5187 Us Route 60 E, Ste 6, Huntington, WV 25705-2076 Ph: (304) 691-8800 | Mr Russell L Fry Ii, MD 5187 Us Route 60 E, Ste 6, Huntington, WV 25705-2076 Ph: (304) 691-8800 |
News Archive
A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in a clinical trial in Australia for medically refractory epilepsy.
BD Biosciences, a segment of BD, announced today a further expansion of its Research Grant program, adding $100,000 worth of reagents, cell culture tools and labware to support promising stem cell research.
Researchers at Osaka University have developed a computer method that uses magnetic resonance imaging (MRI) and machine learning to rapidly forecast genetic mutations in glioma tumors, which occur in the brain or spine. The work may help glioma patients to receive more suitable treatment faster, giving better outcomes.
Ironwood Pharmaceuticals, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the offering have not yet been determined.
› Verified 4 days ago
Stephanie A Skolik, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1616 13th Ave, Suite 3b, Huntington, WV 25701 Phone: 304-525-1404 Fax: 304-523-9763 | |
Mr. David Wellington Cook, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1340 Hal Greer Blvd, Attn: Tammie Silva, Huntington, WV 25701 Phone: 304-522-1802 Fax: 304-529-6752 | |
Dina Christina Blom, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1508 6th Ave, Huntington, WV 25701 Phone: 304-522-8311 Fax: 304-522-8313 | |
Dr. Craig Michael Morgan, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1611 13th Ave, Huntington, WV 25701 Phone: 304-522-6500 Fax: 304-522-1353 | |
Dr. Manik Goel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5187 Us Route 60 Ste 6, Marshall Eye Surgeons East Hills Professional Center, Huntington, WV 25705 Phone: 304-691-8803 | |
Dr. Vishal Verma, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5187 Us Route 60, Suite 6, Huntington, WV 25705 Phone: 304-691-8800 Fax: 304-302-0221 |